589 related articles for article (PubMed ID: 27191524)
21. [Alopecia areata in animal models--new insights into pathogenesis and treatment of a T cell-mediated autoimmune disorder].
Freyschmidt-Paul P; Happle R; Hoffman R
J Dtsch Dermatol Ges; 2004 Apr; 2(4):260-73. PubMed ID: 16285322
[TBL] [Abstract][Full Text] [Related]
22. Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo.
Vu M; Heyes C; Robertson SJ; Varigos GA; Ross G
Clin Exp Dermatol; 2017 Dec; 42(8):942-944. PubMed ID: 29034491
[No Abstract] [Full Text] [Related]
23. Oxidative stress and autoimmune skin disease.
Shah AA; Sinha AA
Eur J Dermatol; 2013; 23(1):5-13. PubMed ID: 23420016
[TBL] [Abstract][Full Text] [Related]
24. Treatment of alopecia areata: "What is new on the horizon?".
Hordinsky MK
Dermatol Ther; 2011; 24(3):364-8. PubMed ID: 21689246
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of thyroid autoimmunity in patients with alopecia areata and vitiligo: a controlled study.
Díaz-Angulo S; López-Hoyos M; Muñoz-Cacho P; López-Escobar M; González-López MA
Australas J Dermatol; 2015 May; 56(2):142-3. PubMed ID: 25900633
[No Abstract] [Full Text] [Related]
26. Alopecia areata: a review of disease pathogenesis.
Rajabi F; Drake LA; Senna MM; Rezaei N
Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718
[TBL] [Abstract][Full Text] [Related]
27. Alopecia areata and universalis in the Smyth chicken model for spontaneous autoimmune vitiligo.
Smyth JR; McNeil M
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):211-5. PubMed ID: 10674368
[TBL] [Abstract][Full Text] [Related]
28. Therapy of alopecia areata: on the cusp and in the future.
Price VH
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):207-11. PubMed ID: 14582675
[TBL] [Abstract][Full Text] [Related]
29. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells.
McElwee KJ; Hoffmann R; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Zöller M
J Invest Dermatol; 2002 Dec; 119(6):1426-33. PubMed ID: 12485450
[TBL] [Abstract][Full Text] [Related]
30. Innate immune mechanisms in vitiligo: danger from within.
Richmond JM; Frisoli ML; Harris JE
Curr Opin Immunol; 2013 Dec; 25(6):676-82. PubMed ID: 24238922
[TBL] [Abstract][Full Text] [Related]
31. Alopecia areata and vitiligo - partners in crime or a case of false alibis.
Tobin DJ
Exp Dermatol; 2014 Mar; 23(3):153-4. PubMed ID: 24372718
[TBL] [Abstract][Full Text] [Related]
32. Alopecia areata: autoimmunity--the evidence is compelling.
Kalish RS; Gilhar A
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
[TBL] [Abstract][Full Text] [Related]
33. Colocalization of vitiligo and alopecia areata presenting as poliosis.
Walker A; Mesinkovska NA; Boncher J; Tamburro J; Bergfeld WF
J Cutan Pathol; 2015 Feb; 42(2):150-4. PubMed ID: 25388912
[TBL] [Abstract][Full Text] [Related]
34. High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease.
Čeović R; Desnica L; Pulanić D; Serventi Seiwerth R; Ilić I; Grce M; Mravak Stipetić M; Klepac Pulanić T; Bilić E; Bilić E; Milošević M; Vrhovac R; Nemet D; Pavletic SZ
Croat Med J; 2016 Jun; 57(3):229-38. PubMed ID: 27374824
[TBL] [Abstract][Full Text] [Related]
35. Topical immunotherapy with diphenylcyclopropenone-induced vitiligo.
Kutlubay Z; Engin B; Songur A; Serdaroglu S; Tuzun Y
J Cosmet Laser Ther; 2016 Aug; 18(4):245-6. PubMed ID: 26963903
[TBL] [Abstract][Full Text] [Related]
36. IL-17 inhibition: is it the long-awaited savior for alopecia areata?
Ramot Y; Marzani B; Pinto D; Sorbellini E; Rinaldi F
Arch Dermatol Res; 2018 Jul; 310(5):383-390. PubMed ID: 29497840
[TBL] [Abstract][Full Text] [Related]
37. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
38. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
Wang Y; Li S; Li C
Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
[TBL] [Abstract][Full Text] [Related]
39. Concurrence of alopecia areata and vitiligo at the same anatomical site.
Ozcan D; Cevlik Aydoğan F
Australas J Dermatol; 2012 Aug; 53(3):e61-3. PubMed ID: 22881476
[TBL] [Abstract][Full Text] [Related]
40. The Changing Landscape of Alopecia Areata: The Translational Landscape.
Wang ECE; Christiano AM
Adv Ther; 2017 Jul; 34(7):1586-1593. PubMed ID: 28646392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
